Contraception (Birth Control) and Family Planning PubHealthInfo

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

YEAR: 1968

CATEGORY: Contraception (Birth Control) and Family Planning

TITLE

The effects of oral contraceptives on glucose tolerance.

AUTHORS

Boshell BR; Roddam RF; McAdams GL; Fox OJ

SOURCE

Journal of Reproduction and Fertility Suppl. 5: 77-88. December 1968.

ABSTRACT

To study the effect on carbohydrate metabolism, ovulen was administered to 231 postmenopausal women for 20

days and discontinued for 7, for several cycles. Ovral was administered to 15 women for 21 days and discontinued

for 7 for several cycles. Glucose tolerance tests, whole blood glucose, serum immunoinsulin levels and serum

immunoreactive growth hormone levels conducted. Of 52 patients on Ovulen who had normal glucose tolerance

tests before the start of treatment, 14 became borderline diabetic and 12 became chemically diabetic. Of the 5

obese patients with normal starting glucose tolerance tests, 3 became chemical diabetics and 1 borderline. A

significant degree of carbohydrate intolerance was produced in some of the postmenopausal women by Ovulen, but

the mildness of the effect is suggested since no overt diabetes was precipitated. There was no change in

carbohydrate intolerance produced by the Ovral. The difference in results may have been due to age differences

between the 2 groups. (PubHealth.info Document ID: CONT9T 1006-06)

PubHealth.info NOTE: The author(s) of this article titled, "The effects of oral contraceptives on glucose tolerance.",

is(are) Boshell BR; Roddam RF; McAdams GL; Fox OJ. The source of this article is "Journal of Reproduction and

Fertility Suppl. 5: 77-88. December 1968.". This article was published in 1968 in English language(s).

(PubHealth.info® Document ID: CONT9T 1006-06. All rights reserved with PubHealth.info) PIN: 41006

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.